Zobrazeno 1 - 10
of 11 468
pro vyhledávání: '"oxazolidinones"'
Autor:
Lu H; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Chinese Academy of Medical Sciences Key Laboratory of Anti-DR TB Innovative Drug Research, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China., Han X; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China., Qin D; College of Marine Life Science, Ocean University of China, 5 Yushan Road, Qingdao 266003, China., Sheng L; Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China., Du C; College of Marine Life Science, Ocean University of China, 5 Yushan Road, Qingdao 266003, China., Wang B; Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Department of Pharmacology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, 97 Ma Chang Street, Beijing 101149, China., Zhao H; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Chinese Academy of Medical Sciences Key Laboratory of Anti-DR TB Innovative Drug Research, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China., Lu Y; Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Department of Pharmacology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, 97 Ma Chang Street, Beijing 101149, China., Liu Y; Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Tiantan Xili, Beijing 100050, China., Hu HY; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China., Liu Y; College of Marine Life Science, Ocean University of China, 5 Yushan Road, Qingdao 266003, China., Zhang D; Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Chinese Academy of Medical Sciences Key Laboratory of Anti-DR TB Innovative Drug Research, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Xian Nong Tan Street, Beijing 100050, China.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Sep 26; Vol. 67 (18), pp. 16088-16106. Date of Electronic Publication: 2024 Sep 05.
Autor:
Strydom N; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA., Ernest JP; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA., Imperial M; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA., Solans BP; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA., Wang Q; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA., Tasneen R; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Tyagi S; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Soni H; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Garcia A; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Bigelow K; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Gengenbacher M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.; Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, NJ, USA., Zimmerman M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA., Xie M; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA., Sarathy JP; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA., Yang TJ; TB Alliance, New York, NY, USA., Dartois V; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.; Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, NJ, USA., Nuermberger EL; Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA., Savic RM; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy, University of California, San Francisco, CA, USA. rada.savic@ucsf.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 25; Vol. 15 (1), pp. 7311. Date of Electronic Publication: 2024 Aug 25.
Autor:
Kirkegaard C; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari. Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain., Parramón-Teixidó CJ; Pharmacy Service, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Campus Hospitalari. Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain., Morales-Comas C; Department of Breast Surgical Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain., Clemente Bautista S; Pharmacy Service, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Campus Hospitalari. Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain., Rivero Deniz J; Department of Breast Surgical Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Campus Hospitalari, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain., Fernández-Hidalgo N; Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Campus Hospitalari. Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. nuria.fernandezhidalgo@vallhebron.cat.; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. nuria.fernandezhidalgo@vallhebron.cat.; CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. nuria.fernandezhidalgo@vallhebron.cat.
Publikováno v:
Infection [Infection] 2024 Aug; Vol. 52 (4), pp. 1585-1593. Date of Electronic Publication: 2024 May 01.
Autor:
Milosevic TV; Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Vertenoeil G; Signal Transduction and Molecular Hematology Unit (SIGN), de Duve Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium.; Ludwig Institute for Cancer Research, Brussels, Belgium., Vainchenker W; UMR 1170, Institut National de la Santé et de la Recherche Médicale, Université de Paris-Sud & Institut Gustave Roussy, Villejuif, France., Tulkens PM; Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Constantinescu SN; Signal Transduction and Molecular Hematology Unit (SIGN), de Duve Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium.; Ludwig Institute for Cancer Research, Brussels, Belgium.; WELBIO Department, WEL Research Institute, Wavre, Belgium.; Nuffield Department of Medicine, Ludwig Institute for Cancer Research, University of Oxford, Oxford, United Kingdom., Van Bambeke F; Pharmacologie cellulaire et moléculaire, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Oct 08; Vol. 68 (10), pp. e0053324. Date of Electronic Publication: 2024 Sep 19.
Autor:
Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia., Nelson AJ; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia., Kastelein JJP; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Ditmarsch M; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Hsieh A; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Johnson J; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Curcio D; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Kling D; NewAmsterdam Pharma B.V, Naarden, The Netherlands., Kirkpatrick CF; Midwest Biomedical Research, Addison, Illinois, USA., Davidson MH; NewAmsterdam Pharma B.V, Naarden, The Netherlands.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70010.
Autor:
Lee SM; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi SC; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Mun KR; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Seo JY; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Cho YL; LegoChem BioSciences, Seoul, Republic of Korea., Shim TS; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lim HS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2024 Jul; Vol. 64 (7), pp. 849-859. Date of Electronic Publication: 2024 Mar 04.
Autor:
Tong SY; School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China., Ye K; School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China., Wang WX; School of Pharmacy, Chongqing Three Gorges Medical College, Chongqing 404120, China. Electronic address: wangwenxiang@cqtgmc.edu.cn., Ai HL; School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China. Electronic address: aihonglian05@163.com.
Publikováno v:
Fitoterapia [Fitoterapia] 2024 Jun; Vol. 175, pp. 105941. Date of Electronic Publication: 2024 Apr 02.
Autor:
Zhang GX; Medical School of Chinese PLA, Graduate School of Chinese, PLA General Hospital, Beijing, 100853, China.; Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, 28 Fu Xing Road, Beijing, 100853, China.; Department of Health Services, General Hospital of Central Theater Command, Wuhan, 430060, China., Liu TT; Department of Pulmonary and Critical Care Medicine, The Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China., Ren AX; Medical School of Chinese PLA, Graduate School of Chinese, PLA General Hospital, Beijing, 100853, China.; Department of Neurology, Second Medical Center of PLA General Hospital, Beijing, 100853, China., Liang WX; Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, 28 Fu Xing Road, Beijing, 100853, China., Yin H; Medical Supplies Center, PLA General Hospital, Beijing, 100853, China., Cai Y; Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center, PLA General Hospital, 28 Fu Xing Road, Beijing, 100853, China. caicai_hh@126.com.
Publikováno v:
Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 787-800. Date of Electronic Publication: 2024 May 08.
Autor:
Boshoff HIM; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Young K; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Ahn YM; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Yadav VD; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Crowley BM; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Yang L; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Su J; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Oh S; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Arora K; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Andrews J; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Manikkam M; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Sutphin M; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Smith AJ; Mycobacterial Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft Collins, Colorado 80521, United States., Weiner DM; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Piazza MK; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Fleegle JD; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Gomez F; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Dayao EK; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Prideaux B; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Zimmerman M; Hackensack Meridian Health Center for Discovery & Innovation, Nutley, New Jersey 07110, United States., Kaya F; Hackensack Meridian Health Center for Discovery & Innovation, Nutley, New Jersey 07110, United States., Sarathy J; Hackensack Meridian Health Center for Discovery & Innovation, Nutley, New Jersey 07110, United States., Tan VY; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States., Via LE; Tuberculosis Imaging Program, Division of Intramural Research, National Insititute of Allergy and Infectious Disease, National Insititutes of Health, Bethesda, Maryland 20892, United States., Tschirret-Guth R; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Lenaerts AJ; Mycobacterial Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft Collins, Colorado 80521, United States., Robertson GT; Mycobacterial Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft Collins, Colorado 80521, United States., Dartois V; Mycobacterial Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Ft Collins, Colorado 80521, United States., Olsen DB; Merck & Co., Inc., West Point, Pennsylvania 19486, United States., Barry CE 3rd; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institutes of Health, Bethesda, Maryland 20892, United States.
Publikováno v:
ACS infectious diseases [ACS Infect Dis] 2024 May 10; Vol. 10 (5), pp. 1679-1695. Date of Electronic Publication: 2024 Apr 06.
Autor:
Osowicki J; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Diseases Unit, Department of General Medicine, Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: joshua.osowicki@rch.org.au., Hamilton F; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Infection Sciences, North Bristol NHS Trust, Bristol, UK., Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Marks M; Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Hospital for Tropical Diseases, University College London Hospital, London, UK; Division of Infection & Immunity, University College London, London, UK., McCreary EK; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., McDonald EG; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Ryder JH; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA., Tong SYC; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 May; Vol. 30 (5), pp. 570-573. Date of Electronic Publication: 2024 Feb 07.